Terumo (TRUMY)
(Delayed Data from OTC)
$19.03 USD
+0.25 (1.31%)
Updated Sep 23, 2024 10:49 AM ET
2-Buy of 5 2
C Value C Growth A Momentum B VGM
Company Summary
Terumo Corporation is engaged in the manufacture and sales of medical products and equipment. The products offered by the Company covers General Hospital Products, Cardiac & Vascular Products, Blood Transfusion Products and Consumer Healthcare Products. General hospital products offered by it include Disposable Medical Equipment, Medical Electronic Products, Diabetes Care Products, CAPD Systems and Pharmaceuticals; Cardiac & Vascular Products include Interventional Systems, Cardiovascular Systems and Artificial Vascular Grafts. Terumo's Blood Transfusion products include blood bags, blood filter, filter in line, blood administration sets and apheresis, while consumer healthcare products include ear thermometer, electronic thermometer, basal body thermometer, electronic sphygmomanometer, urine test strip and leg compression stockings. Terumo Corporation is headquartered in Tokyo, Japan.
Company Summary
General Information
Terumo Corp
2-44-1 Hatagaya Shibuya-ku
Tokyo, M0 151-0072
Phone: 813-3374-8111
Fax: 813-3374-8399
Email: kouhou_terumo01@terumo.co.jp
Industry | Medical - Products |
Sector | Medical |
Fiscal Year End | March |
Last Reported Quarter | 6/30/2024 |
Exp Earnings Date | 11/12/2024 |
EPS Information
Current Quarter EPS Consensus Estimate | NA |
Current Year EPS Consensus Estimate | 0.68 |
Estimated Long-Term EPS Growth Rate | NA |
Exp Earnings Date | 11/12/2024 |
Price and Volume Information
Zacks Rank | |
Yesterday's Close | 18.79 |
52 Week High | 20.60 |
52 Week Low | 12.56 |
Beta | 0.65 |
20 Day Moving Average | 348,878.56 |
Target Price Consensus | 0.00 |
4 Week | -3.36 |
12 Week | 14.76 |
YTD | 15.18 |
4 Week | -4.52 |
12 Week | 9.89 |
YTD | -3.66 |
Shares Outstanding (millions) | 1,490.70 |
Market Capitalization (millions) | 28,004.24 |
Short Ratio | NA |
Last Split Date | 4/15/2019 |
Dividend Yield | 0.50% |
Annual Dividend | $0.09 |
Payout Ratio | 0.23 |
Change in Payout Ratio | NA |
Last Dividend Payout / Amount | NA / $0.00 |
Fundamental Ratios
P/E (F1) | 27.63 |
Trailing 12 Months | NA |
PEG Ratio | NA |
vs. Previous Year | 36.36% |
vs. Previous Quarter | NA |
vs. Previous Year | 5.61% |
vs. Previous Quarter | NA% |
Price/Book | 3.08 |
Price/Cash Flow | 22.11 |
Price / Sales | 4.45 |
6/30/24 | Pending Next EPS Report |
3/31/24 | NA |
12/31/23 | 8.26 |
6/30/24 | Pending Next EPS Report |
3/31/24 | NA |
12/31/23 | 5.89 |
6/30/24 | 2.98 |
3/31/24 | 1.90 |
12/31/23 | 1.90 |
6/30/24 | 1.72 |
3/31/24 | 1.15 |
12/31/23 | 1.13 |
6/30/24 | Pending Next EPS Report |
3/31/24 | NA |
12/31/23 | 11.14 |
6/30/24 | Pending Next EPS Report |
3/31/24 | NA |
12/31/23 | 11.14 |
6/30/24 | Pending Next EPS Report |
3/31/24 | 15.28 |
12/31/23 | NA |
6/30/24 | 6.09 |
3/31/24 | 6.14 |
12/31/23 | 5.53 |
6/30/24 | Pending Next EPS Report |
3/31/24 | 1.58 |
12/31/23 | NA |
6/30/24 | 0.11 |
3/31/24 | 0.06 |
12/31/23 | 0.06 |
6/30/24 | 10.12 |
3/31/24 | 5.35 |
12/31/23 | 5.81 |